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Abstract – Osteochondrosis/osteoarthrosis (OC/OA) are common terms for various joint patholo-
gies that occur in pigs. Pathologies that may contribute to these disorders have been described, but the
primary cause(s) remain unknown. We hypothesised that as OC has some similarities to
dyschondroplasia, which involves a failure of growth plate chondrocytes to fully differentiate and hy-
pertrophy, treatment with 25-hydroxyvitamin D3 (25-D) might reduce the incidence and/or severity
of lesions in pigs, as it does in chickens with dyschondroplasia. Control pigs were fed a commercial
diet ad libitum. In the treated group this diet was supplemented with 25-D at 0.1mg/kg. Ten pigs from
each of the control and treated groups were sampled at 7, 12, 16 and 21 weeks. Treatment with 25-D
had no effect on the incidence or severity of OC/OA lesions. Cartilage dry weight, total collagen con-
tent and proteoglycan content, and plasma levels of total calcium, inorganic phosphorous, vitamin C,
insuline-like growth factor-I, parathyroid hormone and tumour necrosis factor alpha were unaffected
by treatment. In addition, none of these parameters were correlated with the incidence or severity of
OC/OA lesions. The mRNA expression levels of 21 out of 23 genes assayed by RT-PCR were unal-
tered in articular cartilage from OA lesion samples as compared to normal articular cartilage. How-
ever, collagen type II was reduced and collagen type X increased in OA lesion and near lesion
samples. These results suggest that OA in pigs may share some features of osteoarthritis in other
mammalian species.
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Résumé – Différences observées dans les paramètres métaboliques et l’expression des gènes liés
à l’ostéochondrite et à l’arthrose chez le porc ayant ingéré de la 25-hydroxyvitamine D3. Ostéo-
chondrite et arthrose (OC/AR) sont des termes courants désignant les diverses pathologies des articu-
lations survenant chez le porc. Les maladies pouvant contribuer à ces troubles ont été décrites, mais
les causes premières demeurent inconnues. Nous avons fait l’hypothèse que, puisque l’ostéochon-
drite a quelques similarités avec la dyschondroplasie, qui entraîne une incapacité de la plaque endo-
chondriale à se différencier et à s’hypertrophier, le traitement par la 25-hydroxyvitamine D3 (25-D)
pourrait réduire l’incidence et/ou la sévérité des lésions chez le porc, comme elle le fait chez les pou-
lets atteints de dyschondroplasie. Des porcs témoins ont été nourris à volonté par des rations commer-
ciales. Dans le groupe des porcs traités, cette ration a été complétée par de la 25-D à 0,1 mg/kg. Dix
porcs provenant de chaque groupe (témoin et traité) ont été examinés aux semaines 7, 12, 16 et 21. Le
traitement par la 25-D n’a eu aucun effet sur l’incidence ou la sévérité des lésions OC/AR. Le poids
sec des cartilages, le contenu total en collagène et en protéoglycanes, et les taux plasmatiques en cal-
cium total, en phosphore inorganique, en vitamine C, en facteur de croissance proche de l’insuline-I
(IGF-I), en hormone parathyroïdienne, et en facteur de nécrose des tumeurs-α (TNFα), n’ont pas été
affectés par le traitement. De plus, aucun de ces paramètres n’était corrélé à l’incidence ou à la sévéri-
té des lésions OC/AR. Les niveaux d’expression de l’ARNm de 21 gènes sur 23 testés en RT-PCR
n’étaient pas modifiés dans les cartilages articulaires provenant de prélèvements sur des lésions d’ar-
throse, comparé au cartilage articulaire normal. Cependant, le collagène de type II était réduit et le
collagène de type X était augmenté dans les lésions d’arthrose et autour de ces lésions. Ces résultats
suggèrent que l’arthrose chez le porc pourrait partager certaines caractéristiques de l’arthrose chez
d’autres espèces de mammifères.
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1. INTRODUCTION
Osteochondrosis and osteoarthrosis
(OC/OA) are collective terms for various
joint disorders in pigs. These joint disorders
are a widespread problem resulting in lame-
ness and poor welfare. The primary cause(s)
of OC/OA are unknown, although joint dis-
eases have been linked with various dietary
deficiencies such as vitamin D, calcium and
other minerals [19]. It has also been recog-
nised that there is a genetic component to
OC/OA [1, 14, 15, 19, 20, 43, 44]. Unfortu-
nately, the criteria used for selection in com-
mercial pig breeding programs, such as fast
growth and reduced backfat thickness tend
to be associated with OC/OA [25].
A number of studies have described var-
ious pathologies that may ultimately con-
tribute to OC/OA. OC in pigs involves a
failure of growth plate chondrocyte hyper-
trophy, leading to a perturbation of endo-
chondral ossification in the growth plate.
This is often assumed to be the cause of, or
lead to, various pathologies associated with
OC, including osteoarthritis and osteoarthrosis
involving the articular-epiphyseal joint carti-
lage of the fore– and hind limbs [6, 19, 32, 35].
Meat-type (broiler) poultry exhibit a similar
inhibition of endochondral ossification in the
growth plate termed dyschondroplasia [8],
the incidence of which can be reduced by
including 25-hydroxyvitamin D3 (25-D) in
the feed [40].
We postulated that feeding 25-D to pigs
might alleviate OC and associated joint pa-
thologies. To investigate this possibility, we
studied the effect of feeding 25-D to pigs on
the prevalence of OC/OA from weaning un-
til slaughter. In addition, we determined the
correlation of a number of biochemical and
molecular parameters with the occurrence
of OC/OA. This was achieved by a combi-
nation of several different approaches:
(1) gross and histopathological examina-
tion of joint articular-epiphyseal cartilage
at different time points from weaning until
slaughter; (2) measurement of the levels of
various biochemical markers of bone me-
tabolism/pathology in samples of blood or
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cartilage; (3) comparison of the levels of
expression of putative candidate genes for
OC/OA in lesion and normal articular carti-
lage from control pigs.
2. MATERIALS AND METHODS
2.1. Animals
Two hundred 3-week old weaned male
pigs reared on a commercial farm, with a
history of a high incidence of OC/OA in
growing and finishing pigs, were divided at
random into two groups, control and
treated. The pigs were the offspring of
White German Duroc sires and Pig Im-
provement Company Camborough dams.
Control animals were fed a standard com-
mercial grower diet ad libitum during the
growing period before being transferred to
a commercial finishing diet. Treated ani-
mals were fed the same diets supplemented
with 0.1 mg/kg 25-D. The pigs were
housed in pens (50 pigs per pen) with part
solid concrete floors and part concrete slats
with straw. Ten pigs chosen at random from
each group were weighed and slaughtered
at 7, 12, 16 and 21 weeks. The leg joints (el-
bow and stifle) from all 4 legs were scored
for OA (gross pathology) and sections from
these joints processed for histopathology
(OC/OA). In addition, samples of blood
and articular cartilage were taken for bio-
chemical analysis, and separate articular
cartilage samples processed for the extrac-
tion of total RNA. Blood samples were col-
lected in EDTA coated tubes with thorough
mixing. Plasma was isolated from aliquots
of blood by centrifugation at 3000 × g for
10 min and stored at –70 oC until analysis.
In addition, 12 control pigs were sampled at
24 weeks of age solely to obtain RNA from
normal and OA lesion articular cartilage.
2.2. Gross pathology
Elbow and stifle joints were opened and
the articular surfaces examined for evi-
dence of surface lesions. Joints were scored
for severity of OA using an arbitrary scor-
ing system from 0 to 5 as follows: 0 – no le-
sion, 1 – very mild or early lesion, 2 – mild
lesions, 3 – moderate lesions, 4 – marked
lesions, 5 – severe lesions [38].
2.3. Histopathology
Bones from the joints were sawn into
5 mm slices to encompass both the articular
cartilage and growth plate. The slices were
fixed in 10% neutral buffered formalin and
then subjected to decalcification in EDTA.
Decalcified bones were trimmed and pro-
cessed through to paraffin wax for
histopathological examination using stan-
dard techniques. Sections (4 µm) were
mounted on glass slides, stained with
haematoxylin and eosin and examined us-
ing light microscopy. Representative sec-
tions were scored as above for both
articular (OA) and growth plate (OC) le-
sions.
2.4. Biochemical analysis
Plasma: (1) Total calcium and inorganic
Phosphorous. Both were determined by
colorimetric methods using commercially
available kits (Wako Chemicals GmbH,
Neuss, Germany). (2) Vitamin C. Ascorbic
acid concentrations were measured by
colorimetric assay using folin phenol re-
agent [22].
Cartilage extracellular matrix: (1) Dry
weight. Weighed samples of articular carti-
lage were heated at 107 oC for 48 hours and
re-weighed. This was repeated after a fur-
ther 24 hours to check that there was no fur-
ther change in weight. (2) Proteoglycans.
Articular cartilage samples were weighed
and analysed for proteoglycan content using
1,9-dimethylmethylene blue [9]. (3) Colla-
gen. The collagen content of articular carti-
lage was assayed by measuring the amount
of hydroxyproline in weighed samples [4].
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Immunoassays: 1,25-dihydroxyvitamin D
(1,25-D) and 25-D were measured in
plasma samples using commercial radio-
immunoassay kits (IDS, Boldon, UK).
Plasma samples were further analysed by
ELISA for tumour necrosis factor alpha
(TNFα) (Endogen Inc, Massachusetts,
USA) and insulin-like growth factor-I
(IGF-I) (IDS). Parathyroid hormone (PTH)
was assayed in plasma by a specific two-
site radioimmunoassay (Immutopics, Cali-
fornia, USA).
2.5. Molecular analysis
RNA extraction: Chondrocytes were iso-
lated from articular cartilage samples using
a method previously developed for growth
plate chondrocytes [7]. None of the pigs fed
25-D were sampled so as to avoid possible
treatment effects. Cartilage was taken from
the sites of OA lesions and also from areas
of normal cartilage adjacent to OA lesions,
where possible. These samples were re-
ferred to as lesion and near lesion, respec-
tively. Control samples from pigs without
clinical signs of lesions from matched areas
of the joint surface were also taken. Sterile
scalpel blades were used at all times. The
articular cartilage was chopped into small
pieces and the tissue incubated in a shaking
water bath for 4 hours at 37 oC in
Dulbecco’s modified Eagle’s medium
(DMEM), containing 0.4% collagenase
and 0.2% hyaluronidase. After passage
through a 100 µm filter to remove undi-
gested material, the cells were washed
3 times with DMEM and pelleted by
centrifugation. Total RNA was extracted
from isolated chondrocytes using Ultraspec
II according to the manufacturers instruc-
tions (Biotecx, USA). Briefly, cells were
resuspended in 1 mL of Ultraspec II and the
suspension passed repeatedly through an
18-gauge needle. After incubation on ice
the RNA was extracted with chloroform and
the aqueous phase recovered. The RNA was
then bound to RNATack resin (Biotecx) in
the presence of isopropanol and recovered
by brief centrifugation. After washing
twice with 75% ethanol the RNA was
eluted in a small volume of 10 mM Tris
(pH 7.0). The RNA was then treated with
DNAse I (DNA-Free; Ambion, USA) to re-
move any contaminating genomic DNA be-
fore RT-PCR.
RT-PCR: Total RNA was reverse tran-
scribed with random hexamers in aliquots
of 1 µg using the Superscript pream-
plification system (Invitrogen, Paisley, UK)
Control reactions were processed identi-
cally except for the omission of Superscript
(reverse transcriptase) enzyme. Polymer-
ase chain reaction (PCR) was carried out in
a volume of 10 µL in 200 µL thin-walled
tubes using a Robocycler PCR machine
(Stratagene, UK). The reaction contained
TLA buffer [23, 24], 0.05% Tween-20
(Sigma, UK), one unit of Taq polymerase
(ABgene, UK), in the presence of Taqstart
antibody (Clontech, UK) and the equivalent
of 20 ng of target RNA. The final concen-
tration of the primers was 1 µM. The tem-
perature profile of the PCR was 95 oC for
30 s, 60 oC for 60 s and 72 oC for 60 s. The
number of PCR cycles was carefully ti-
trated to ensure that the reactions were in
the exponential phase. PCR products were
run out on 3% NuSieve agarose gels
(Flowgen, UK), stained with ethidium bro-
mide, and a record of the gel made using
the BioRad gel documentation system
(BioRad, UK). For comparison of OA le-
sion and control samples, relative levels of
expression were calculated by densitometric
analysis of gel images using the Scion Image
software package (Scion Corporation,
USA). The expression levels were estimated
in arbitrary units, with the control band as-
signed a value of one. The housekeeping
genes glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) or actin were used as
invariant internal control genes. Each gene
was assayed at least three times and the re-
sults collated and analysed statistically us-
ing a one-sample t-test within the Statview
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statistics package (SAS Institute Inc.). The
two genes that showed differences in ex-
pression levels between samples, collagen
types II and X, were assayed at least a fur-
ther 3 times, comparing mRNA abundance
between control, lesion and near lesion
samples.
Gene specific primers: Candidate genes
were selected from searches of the EMBL
nucleotide sequence database (http://
www.ebi.ac.uk). Gene specific primers
were then designed using the GCG program
Prime (Wisconsin Package version 10.1,
Genetics Computer Group (GCG), Madi-
son, Wisconsin). Genes that were consid-
ered possible candidate genes for OA
included those thought to be involved in
cartilage differentiation and degradation,
such as growth factors and matrix
metalloproteinases, as well as components
of the extracellular matrix that may be al-
tered during cartilage degeneration.
Heterologous cloning of pig collagen
type-II: Using primers specific for the
chicken collagen type II gene and total
RNA from pig articular cartilage, RT-PCR
was carried out as described above, but us-
ing a lower stringency annealing tempera-
ture of 55 oC, to take account of the possible
differences in the sequences of the pig and
chicken genes.
2.6. Statistical analysis
Pig OC/OA scores: Mean scores were
calculated and the scores of control and
treated pigs were compared statistically us-
ing the Mann-Whitney U test for non-para-
metric data.
Pig weights: Pig weights were analysed
using analysis of variance according to
treatment and age within the Statview sta-
tistics software package (SAS Institute
Inc., USA).
Biochemical parameters: The effects of
group (control and treated), age and their
interaction, plus covariates for the effects of
elbow and stifle joint lesion score on the pa-
rameters measured in cartilage and blood
were assessed using analysis of covariance
(Genstat statistics package, Lawes agricul-
tural trust, Rothamsted experimental sta-
tion, Harpenden, UK).
3. RESULTS
3.1. Gross and histopathology
Scores for each joint were assigned on
the basis of gross and histopathological ex-
amination. Histopathology scores for the
control and 25-D treated groups at each
time point are shown in Table I, as well as
the number of pigs with lesions and the
range of lesion scores. Only two animals
(25-D treated group at 12 weeks of age) had
a lesion that involved the growth plate
(OC), where there was a small focus of dis-
ruption to growth plate chondrocyte matu-
ration with fibrosis. All other lesions
involved the articular cartilage and in-
cluded thinning of the articular cartilage,
pitting of the articular surface, necrosis and
cartilage degeneration at both the gross and
cellular levels. Overall scores for the preva-
lence of OC/OA in each age group revealed
that there were few lesions apparent in pigs
from the early age groups (Tab. I). Lesions
became prevalent at 16 weeks with the inci-
dence and severity increasing at 21 weeks.
There were no statistically significant dif-
ferences in incidence or severity of OC/OA
between the control and treated groups at
any age point. However, the mean weight of
the control and treated groups, which did
not differ during the early part of the experi-
ment, was significantly higher in the treated
group at 21 weeks of age (P < 0.01)
(Tab. II).
3.2. Biochemical parameters
(Tabs. III, IV)
None of the parameters measured showed
a significant correlation with OC/OA score
Osteochondrosis/osteoarthrosis in pigs 387
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Table I. Frequency and severity of DJD lesions in leg joints of control and 25-D treated pigs at different
ages.
Age
(weeks)
Elbow Stifle
Control Treated Control Treated
ms ± sd nl r ms ± sd nl r ms ± sd nl r ms ± sd nl r
7 0.0 ± 0.0 0 – 0.2 ± 0.6 1 0 – 2 0.1 ± 0.3 1 0 – 1 0.0 ± 0.0 0 –
12 0.0 ± 0.0 0 – 0.2 ± 0.6 3 0 – 2 0.6 ± 1.1 3 0 – 3 0.5 ± 0.8 4 0 – 2
16 1.3 ± 1.5 6 0 – 3 1.8 ± 1.6 7 0 – 4 0.3 ± 0.7 2 0 – 3 0.4 ± 1.0 2 0 – 3
21 2.6 ± 2.3 10 0 – 5 3.2 ± 1.5 10 0 – 5 1.5 ± 1.7 8 0 – 5 1.1 ± 1.0 7 0 – 2
ms ± sd: mean score ± standard deviation (n =10). nl: number of pigs in group with lesions. r: range of lesion scores.
Table II. Pig weights in the 25-D treated and control groups.
Age
(weeks)
Weight (kg)
Control Treated
7 15.30 ± 2.25 13.88 ± 3.71
12 41.20 ± 3.62 40.75 ± 4.98
16 72.10 ± 5.82 69.80 ± 7.84
21 83.50 ± 4.60 92.50 ± 6.06
Weights are given as the mean ± standard deviation, n = 10.
Table III. Summary of results for biochemical parameters measured in articular cartilage with re-
spect to treatment.
Parameter Age (weeks) Controla Treatmenta S.e.d.b
%PG
7
12
16
21
7.76
9.65
6.69
ND
9.60
9.62
7.27
ND
0.855
%Collagen
7
12
16
21
10.11
11.55
12.27
ND
9.37
11.53
11.94
ND
1.127
%DW
7
12
16
21
20.54
21.14
21.26
ND
21.41
22.77
21.11
ND
2.106
a Values given are the means (n = 10). b Standard error of the difference of the means. PG: proteoglycan. DW:
dry weight. ND: not determined.
of the elbow or stifle joints at any age.
However, a number of the parameters mea-
sured showed statistical significance with
age. For example, PTH (P < 0.05) and
IGF-I (P < 0.001) increased, and calcium
(P < 0.001), 1, 25-D (P < 0.001) and vita-
min C (P < 0.001) decreased significantly
with age. However, several other correla-
tions with age were not due to trends, but to
increased or decreased measurements at an
isolated time point (inorganic phosphorous,
P < 0.01; 25-D, P < 0.001; TNFα, P < 0.001).
Only two parameters showed statistical signif-
icance with treatment. Levels of the vitamin D
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Table IV. Summary of results for biochemical parameters measured in blood with respect to treat-
ment.
Parameter Age (weeks) Controla Treateda S.e.d.b
Total Ca (mM) 7
12
16
21
2.35
2.14
1.93
2.00
2.38
2.12
2.17
1.85
0.124
Pi (mg/dL) 7
12
16
21
11.08
11.09
9.53
12.02
11.26
11.80
9.07
10.56
0.947
Vit C (mg/dL) 7
12
16
21
1.291
1.318
0.976
0.739
1.328
1.357
0.859
0.700
0.096
1,25 D (pmol/mL) 7
12
16
21
592.4
446.4
377.6
400.7
673.9
550.7
444.6
446.5
41.84
25-D (pmol/mL) 7
12
16
21
50.2
108.3
178.5
117.9
328.2
343.8
390.2
363.7
18.74
IGF-I (ng/mL) 7
12
16
21
30.2
63.0
114.8
99.3
24.0
66.7
127.9
87.5
1.39
PTH (pg/mL) 7
12
16
21
0.37
3.10
1.15
7.72
0.64
2.42
1.84
2.68
2.47
TNFα (pg/mL) 7
12
16
21
8.0
26.7
6.7
8.0
6.2
24.0
6.4
7.7
1.63
a Values given are the means (n = 10). b Standard error of the difference of the means. Ca: total calcium. Pi: inor-
ganic phosphorous. Vit C: vitamin C.
metabolites, 25-D (P < 0.001) and 1,25-D
(P < 0.001) were both significantly higher
in the treated group (Tab. IV).
3.3. Cloning of the pig homologue
of collagen type II
After PCR at the reduced annealing tem-
perature of 55 oC agarose gel electrophore-
sis revealed a complex pattern of minor
bands with a major band of approximately
the correct size at 300 base pairs. This band
was cloned and sequenced and the resulting
330 base pair sequence compared with se-
quences in the EMBL database. This re-
vealed that the cloned band had high
homology with a number of vertebrate col-
lagen type II genes, including human,
horse, rabbit, rat, mouse and chicken at the
nucleotide and translated amino acid se-
quence levels (86% to 96% identity over
248 to 330 base pairs/110 amino acids) and
it was therefore concluded that this was a
fragment of the pig collagen type II gene.
Oligonucleotide primers specific for this
sequence were synthesised and included in
the candidate gene screen described in Sec-
tion 3.4.
3.4. Gene expression
Gene expression levels were assayed by
RT-PCR for 25 different putative candidate
genes, including collagen type II. The se-
quence of the primers and the size of the
PCR product generated are given in Ta-
ble V. In an initial screen 23 of the 25 pig
genes assayed were amplified from articu-
lar cartilage, with only two genes, mmp and
msp1, giving no detectable signal under the
assay conditions used. Of these 23 genes
assayed further using semi-quantitative
RT-PCR, 21 showed no difference between
control and OA lesion samples of articular
cartilage (e.g. Fig. 1). The remaining two
genes, collagen types II and X, showed con-
sistently altered levels of abundance in OA
lesion and near lesion samples, as com-
pared to controls. Collagen type II was
downregulated (P < 0.01) and collagen
type X upregulated (P < 0.01) in lesion and
near lesion samples of articular cartilage
(Fig. 2).
4. DISCUSSION
This study tested the hypothesis that 25-D,
which is known to decrease the occurrence of
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Figure 1. Relative levels of gene expression in total RNA from normal control (lanes C1 and C2) and
DJD lesion (lanes L1 and L2) pig articular cartilage samples. Lanes CRT– and LRT– are negative
control reactions. 100, 200 and 300 base pair markers are indicated on right-hand side of gel. Genes
assayed are: (a) ADAM and TGFβ3. (b) MMP13 and the control gene actin.
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Table V. Genes assayed in cartilage samples from normal and DJD lesion joints.
Gene Primer Primer sequence (5’ – 3’)a Fragment size
(bp)b
tenascin PTEN
ACAGAGGTGACGGAAGAAAC
TTCAGGTGTAGGCAGGTAAGG
255
collagen VII PCOL7
ACTGAGTACCAAGTGACAGTG
TGTGGTATTCTGGATGGTCAG
210
link protein PLINK
CCAAGCTAACTTCAGATTACC
TCACCTCACACTTATATCTCC
180
aggrecan PAGG
CGAGGAGCAGGAGTTTGTCAAC
ATCATCACCACGCAGTCCTCTC
177
osteopontin POST
GAGCAGTCCAAAGAATACACG
TCCAGAGCCACACACATATAC
332
TGF-α PTGFα
AAGAAGCAGGCCATTACCGC
AGTGTTTTCGGACCTGGCAG
103
TGF-β1 PTGF1 AAGGAAAAGGAAGCCCATAG
CACCCCAAATTCATCTTCAC
276
TGF-β2 PTGF2 GTTGTTGCCCTCCTACAGAC
CTGAGAACCCTGCTATGCTG
243
TGF-β3 PTGF3 AAAGCAACAGACCTCACCTCG
CCTTCCCCTAATCAAACCCAC
153
TGF-β type III-R PTGFR GTCGTGTTCCTGCTCAACTC
CCTTTCCTCTGTTTCTGCTG
156
GHR PGHR
ACCACAGAAAGCCTTACCAC
TCACATAGCCACACGATGAG
184
PTHR PPTHR
CCTCCATTGTGCTCAACTTC
AAAGTCCAGTGCCAATGTCC
344
IGF-I PIGFI
ACAAGCCCACAGGGTACGGCT
CCTGAACTCCCTCTACTTGTG
220
GEMBP PGEM
GCTCAAGTCCAAATCCTGCC
TGAACACCAACCACGCTCTC
299
c-myc PMYC
GAGACACTTTTCCCTGTCGC
CTTCCAGATATCCTCGCTGG
261
MMP PMMP
TACACACCTTCCATGACTCCT
ACCATTCATTCCCATAGTCCT
267
MMP-1 PMMP1
TCTCACCCTTGACCTTCACC
GAGCAGCCACACGATACAAG
222
MMP-3 PMMP3
ACCCAAGAAGTATCCACACCCT
TGCTTCAAAGACAGCATCCACT
215
MMP-13 PMMP13
GATGATGAAACCTGGACAAG
ATCAGGAAGCATAAAGTGGC
162
dyschondroplasia in chickens [40], could
reduce the incidence or severity of OC/OA
in pigs. No evidence was found that 25-D
had an influence on the type or severity of
OC/OA lesions that developed in the pigs
examined in the present study. However, in
chickens the success of 25-D in preventing
dyschondroplasia is due to its positive ef-
fect on the differentiation of growth plate
chondrocytes, which fail to fully differenti-
ate in this disorder. As few lesions typical of
OC (dyschondroplasia) in the growth plate
of the pigs were encountered during this
study, the hypothesis that 25-D can reduce
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MSP PMSP
CGCACACTGCTTCCAAAATTC
AGCGACACCGATTCTTTCAAC
177
ADAM PADAM
CACATGATTCTGGAACAGAGTG
CATTCCATTTTCCACAGATAGGC
218
PIAP PPIAP
CCAAAGGATGATGCTATGAC
ACTCACACCTTGGAAACCAC
313
endoglin PEND
CGTCCACATCCTCTTCTTGG
AGCAGCAGAGATGATGGAGC
295
collagen type II PCOLII
GCTATGGAGATGACAACCTGGCTC
CACTTACCGGTGTGTTTCGTGCAG
256
collagen type X PCOLX
GCTGCCACATTCTGACACAATC
TGCGCTGAGCATCATTTGAGAC
225
GAPDH PGAP
ACCCCTTCATTGACCTCCAC
ATACTCAGCACCAGCATCGC
179
ACTIN PACT
TGGTGGGTATGGGTCAGAAAG
TCGTTGTAGAAGGTGTGGTGC
148
aPrimers are listed as sense followed by antisense. bBase pairs.
Table V. (Continued)
Figure 2. Relative levels of gene expression in total RNA from normal control (C), DJD lesion (L) and
near lesion (NL) pig articular cartilage samples. Col X = type X collagen. Col II = type II collagen.
the incidence of growth plate lesions of OC
was not properly tested. In addition, 25-D
supplementation of the diet did not signifi-
cantly alter any of the parameters measured
in blood and articular cartilage, with the ex-
ception of 25-D and 1,25-D, which as ex-
pected, were significantly increased in the
treated group. It should be noted that an
early study on the effect of vitamin D on the
severity of OC in pigs also found no evi-
dence of a reduction in the pathological
changes associated with OC, although only
12 pigs were examined in this experiment
[39].
The virtual absence of detectable growth
plate lesions was unexpected given the gen-
erally accepted view that early onset lesions
of the epiphyseal growth cartilage of the
A-E complex give rise to later degenerative
changes in articular cartilage [19, 21].
However, a number of studies have reported
the occurrence of articular lesions, more
typical of osteoarthrosis [13, 19, 26, 37].
The changes in gene expression that were
observed in the present study seem to indi-
cate that there may be similarities between
the molecular changes that occur in OC/OA
in pigs and degenerative changes in the ar-
ticular cartilage of other mammals in osteo-
arthrosis or osteoarthritis. The expression
of both collagen types II and X is altered in
osteoarthritic/osteoarthrotic articular carti-
lage, with type II being down regulated or
degraded [27, 42] and type X upregulated
[11, 30], respectively. There is also evidence
that the changes in mRNA levels observed in
the present study may lead to alterations in
the abundance of collagen proteins within the
extracellular matrix. Immunolocalisation of
collagens within the cartilage of pigs with ar-
ticular as well as growth plate lesions of
osteochondrosis showed that there was a re-
duction in the proportion of type II collagen,
and that type X collagen was detected in
osteochondrotic but not normal articular
cartilage [45]. Other studies have found no
evidence of altered expression of type II or
type X collagen in OC [5, 43]. However,
this may reflect differences in sampling
techniques, the individual joints sampled
and the depth to which cartilage is sampled,
or the heterogeneity of the lesions classed as
osteochondritic within and between spe-
cies.
Despite the apparent reduction in type II
collagen detected at the mRNA level in the
present study, there appeared to be no over-
all reduction in the collagen content of the
articular cartilage samples. There are two
possible explanations for this discrepancy.
Firstly, the cartilage samples were analysed
for total collagen content and reduction in
type II collagen may have been compen-
sated for by the increase in type X. Sec-
ondly, the samples analysed were from the
earlier time points of the trial. It was not
possible to process samples for total colla-
gen content from the pigs at 21 weeks and
most RNA samples were from pigs taken at
the end of the trial when the most severe le-
sions were seen. Therefore, as the pathol-
ogy associated with earlier lesions was less
severe, it is possible that the changes in col-
lagen abundance did not occur until the
later stages of disease progression. One
mechanism by which type II collagen gene
expression may be reduced is through vita-
min C deficiency [12]. In one study dietary
supplementation with vitamin C appeared
to lead to a reduction in the severity of
OC/OA lesions, although the reduction in
overall incidence of lesions was not statisti-
cally significant [16]. However, in the pres-
ent study circulating levels of ascorbic acid
appeared normal, although they did decline
with age, but there was no correlation with
increasing OC/OA lesion score. IGF-I de-
pletion has also been shown to lead to a re-
duction in collagen gene expression [12],
but systemic levels of IGF-I actually in-
creased with age in this study and this ap-
pears to be the norm [29, 36]. Local levels
of IGF-I production were also unchanged,
as measured by mRNA abundance in artic-
ular cartilage. It is possible that different
levels of IGF binding proteins might alter
Osteochondrosis/osteoarthrosis in pigs 393
the levels of active IGF-I, but unfortunately
the reagents to test this were not available.
No changes in the total proteoglycan
(PG) content of the articular cartilage of
OA lesion pigs as compared to normal pigs
were detected in the present study. This is in
agreement with a study of the effect of re-
combinant pig growth hormone, which
induces high levels of OC, on the
glycosaminoglycan content of joint carti-
lage in pigs. Total PG content of articular
cartilage was unchanged, but was reduced
in the deeper layers of the epiphyseal carti-
lage [18]. There are a number of conflicting
reports documenting either increased or de-
creased levels of general PGs, or individual
PG components of the extracellular matrix
in OC. However, changes were restricted to
the growth cartilage and were either un-
changed due to the absence of lesions or not
determined in the articular cartilage of the
joints examined [5, 17, 18, 33]. Nakano et al.
[31] concluded that biochemical changes in
PGs only occur in severely affected joint
cartilage, and not in cartilage with early
OC/OA.
TNFα is known to promote the degrada-
tion of cartilage and bone [2]. It has been
implicated in the inhibition of 1,25-D stim-
ulated extracellular matrix protein synthe-
sis [34] and the activation of catabolic MAP
kinase pathways in articular chondrocytes
[10], which can lead to focal loss of carti-
lage glycosaminoglycans [46]. Despite this
we found no evidence that TNFα is in-
volved in cartilage destruction in OC/OA.
Systemic levels of TNFα were unaltered in
OA lesion affected pigs compared to unaf-
fected controls. However, local production
of TNFαis known to be important in the de-
struction of cartilage in osteoarthritis [46]
and future studies should consider measur-
ing concentrations of TNFα in the synovial
fluid of affected joints.
Due to its central role in calcium homeo-
stasis PTH is of fundamental importance in
the regulation of skeletal integrity [41].
However, although articular chondrocytes
express PTH receptor mRNA they appear
to be unresponsive to treatment with PTH
[3]. This would explain the results of the
present study, in which no correlation be-
tween systemic levels of PTH and OC/OA
lesion status was apparent and no differ-
ence in PTH receptor mRNA levels was de-
tected between lesion and non-lesion
samples.
The increase in the weight of the pigs
was similar in both groups until 16 weeks,
but at 21 weeks was significantly higher in
the treated group, as compared to the con-
trols (Tab. II). This was a rather surprising
result considering that the weight gain of
the treated animals over this 5 week period
was almost double that of the control group.
Clearly this result must be treated with cau-
tion, particularly as the number of pigs in
the groups was so small. It would need to be
repeated on a much larger scale to be con-
sidered significant.
The changes in gene expression ob-
served in the present study in the articular
cartilage of pigs with OA lesions indicate
that the condition may have similarities
with osteoarthritis/osteoarthrosis in mam-
mals. Although it is clear from numerous
studies that OA is not an inflammatory con-
dition. Mice with a targeted inactivation of
one allele of the collagen type II alpha I
gene have an increased prevalence of
osteoarthritis [28]. This is of interest in the
light of the results of the present study that
indicate that the reduction of type II colla-
gen mRNA expression occurred not only in
OA lesion cartilage, but also in adjacent
phenotypically normal articular cartilage.
Although this assessment was based on a
macroscopic examination of the joint carti-
lage, if true, this would suggest that the car-
tilage of the affected joints is predisposed to
develop OA. Further studies will be neces-
sary to test this hypothesis and to document
more fully the molecular changes that char-
acterise the various pathologies associated
with OC/OA in pigs.
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